Last edition
News about Drug Discovery & Development
New Marketing Code for Pharma Industry Issued by Indian Govt
The Department of Pharmaceuticals has issued a new code prohibiting pharma companies from offering gifts and travel facilities to healthcare professionals or their family members.
Drug Discovery & Development | 19/03/2024 | By Manvi | 820
This milestone represents one of the first engineered T-cell programs targeting solid tumors to reach Phase II.
Drug Discovery & Development | 18/03/2024 | By Manvi | 497
Biotheus will grant Hansoh Pharma a license to use the proprietary anti-EGFR/cMet bispecific antibody PM1080/HS-20117 independently developed by Biotheus for the development of antibody-drug conjugates products (ADC Product).
Drug Discovery & Development | 16/03/2024 | By Manvi | 793
Epsilogen and Lonza Achieve Breakthrough in Cancer Treatment with MOv18 IgE Antibody
The companies have successfully completed the Good Manufacturing Practice (GMP) manufacturing of MOv18 IgE, Epsilogen’s leading IgE antibody drug candidate.
Drug Discovery & Development | 07/03/2024 | By Abha | 745
CleanNA Launches CE-IVD Product for Quick and Reliable Viral DNA and RNA Extraction
The company’s Clean Quick Viral DNA/RNA (CE-IVD) extracts viral DNA and RNA from nasopharyngeal or oropharyngeal swab samples preserved in an inactivating viral transport medium.
Drug Discovery & Development | 06/03/2024 | By Manvi | 543
LTS Launches Sorrel Wearable Drug Delivery Platform with Coherus BioSciences
The platform debuts alongside Coherus' UDENYCA® on-body injector (OBI), a solution for administering pegfilgrastim-cbqv, a biosimilar pegfilgrastim utilized post-chemotherapy to mitigate infection risks.
Drug Discovery & Development | 29/02/2024 | By Manvi | 1755
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact System
Accuray Incorporated announced that the team at Quebec's Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is the first in Canada to treat cancer patients using the company's Radixact® radiation therapy delivery system.
Drug Discovery & Development | 13/02/2024 | By Manvi | 281
BIOTRONIK Launches Micro Rx Catheter for Enhanced Guidewire Support in Coronary Interventions
Developed exclusively by BIOTRONIK and manufactured by IMDS, this innovative device marks a significant addition to the company's robust portfolio of interventional solutions in the US.
Drug Discovery & Development | 12/02/2024 | By Manvi | 634
Boehringer Ingelheim and CBmed Forge Partnership to Advance Cancer Treatment Development
The partnership, unveiled with great anticipation, will harness translational medicine approaches to drive the advancement of first-in-class therapies, ultimately aiming to revolutionize the lives of individuals battling cancer.
Drug Discovery & Development | 12/02/2024 | By Manvi | 555
Domrex Pharma Expands Its Reach with Launch of Domrex Pharma USA
Originating in Quebec, Domrex Pharma has successfully positioned itself as a key player in the healthcare industry, catering to hospitals, pharmacies, clinics, and long-term care facilities across Canada.
Drug Discovery & Development | 02/02/2024 | By Manvi | 827
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy